Copyright Reports & Markets. All rights reserved.

Global Streptococcus Pneumoniae Vaccine Market Research Report 2021

Request for Sample of this report
Buy now

1 Streptococcus Pneumoniae Vaccine Market Overview

  • 1.1 Product Overview and Scope of Streptococcus Pneumoniae Vaccine
  • 1.2 Streptococcus Pneumoniae Vaccine Segment by Type
    • 1.2.1 Global Streptococcus Pneumoniae Vaccine Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 7 -Valent
    • 1.2.3 10 -Valent
    • 1.2.4 13 -Valent
    • 1.2.5 15 -Valent
    • 1.2.6 23 -Valent
    • 1.2.7 Other
  • 1.3 Streptococcus Pneumoniae Vaccine Segment by Application
    • 1.3.1 Global Streptococcus Pneumoniae Vaccine Sales Comparison by Application: (2021-2027)
    • 1.3.2 Children under 2 Years of Age
    • 1.3.3 Adults over 65 Years of Age
    • 1.3.4 Addicted Smokers Between the Ages of 19 and 64
    • 1.3.5 Other
  • 1.4 Global Streptococcus Pneumoniae Vaccine Market Size Estimates and Forecasts
    • 1.4.1 Global Streptococcus Pneumoniae Vaccine Revenue 2016-2027
    • 1.4.2 Global Streptococcus Pneumoniae Vaccine Sales 2016-2027
    • 1.4.3 Streptococcus Pneumoniae Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Streptococcus Pneumoniae Vaccine Market Competition by Manufacturers

  • 2.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Streptococcus Pneumoniae Vaccine Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Streptococcus Pneumoniae Vaccine Manufacturing Sites, Area Served, Product Type
  • 2.5 Streptococcus Pneumoniae Vaccine Market Competitive Situation and Trends
    • 2.5.1 Streptococcus Pneumoniae Vaccine Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Streptococcus Pneumoniae Vaccine Players Market Share by Revenue
    • 2.5.3 Global Streptococcus Pneumoniae Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Streptococcus Pneumoniae Vaccine Retrospective Market Scenario by Region

  • 3.1 Global Streptococcus Pneumoniae Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Streptococcus Pneumoniae Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
    • 3.3.1 North America Streptococcus Pneumoniae Vaccine Sales by Country
    • 3.3.2 North America Streptococcus Pneumoniae Vaccine Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
    • 3.4.1 Europe Streptococcus Pneumoniae Vaccine Sales by Country
    • 3.4.2 Europe Streptococcus Pneumoniae Vaccine Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Streptococcus Pneumoniae Vaccine Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Streptococcus Pneumoniae Vaccine Sales by Region
    • 3.5.2 Asia Pacific Streptococcus Pneumoniae Vaccine Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
    • 3.6.1 Latin America Streptococcus Pneumoniae Vaccine Sales by Country
    • 3.6.2 Latin America Streptococcus Pneumoniae Vaccine Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Streptococcus Pneumoniae Vaccine Sales by Country
    • 3.7.2 Middle East and Africa Streptococcus Pneumoniae Vaccine Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Streptococcus Pneumoniae Vaccine Historic Market Analysis by Type

  • 4.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2016-2021)
  • 4.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2016-2021)
  • 4.3 Global Streptococcus Pneumoniae Vaccine Price by Type (2016-2021)

5 Global Streptococcus Pneumoniae Vaccine Historic Market Analysis by Application

  • 5.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2016-2021)
  • 5.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application (2016-2021)
  • 5.3 Global Streptococcus Pneumoniae Vaccine Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Pfizer
    • 6.1.1 Pfizer Corporation Information
    • 6.1.2 Pfizer Description and Business Overview
    • 6.1.3 Pfizer Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Pfizer Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.1.5 Pfizer Recent Developments/Updates
  • 6.2 Sanofi
    • 6.2.1 Sanofi Corporation Information
    • 6.2.2 Sanofi Description and Business Overview
    • 6.2.3 Sanofi Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Sanofi Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.2.5 Sanofi Recent Developments/Updates
  • 6.3 GSK
    • 6.3.1 GSK Corporation Information
    • 6.3.2 GSK Description and Business Overview
    • 6.3.3 GSK Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 GSK Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.3.5 GSK Recent Developments/Updates
  • 6.4 Merck
    • 6.4.1 Merck Corporation Information
    • 6.4.2 Merck Description and Business Overview
    • 6.4.3 Merck Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Merck Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.4.5 Merck Recent Developments/Updates
  • 6.5 Eli Lilly
    • 6.5.1 Eli Lilly Corporation Information
    • 6.5.2 Eli Lilly Description and Business Overview
    • 6.5.3 Eli Lilly Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Eli Lilly Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.5.5 Eli Lilly Recent Developments/Updates
  • 6.6 AstraZeneca
    • 6.6.1 AstraZeneca Corporation Information
    • 6.6.2 AstraZeneca Description and Business Overview
    • 6.6.3 AstraZeneca Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 AstraZeneca Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.6.5 AstraZeneca Recent Developments/Updates
  • 6.7 Abera
    • 6.6.1 Abera Corporation Information
    • 6.6.2 Abera Description and Business Overview
    • 6.6.3 Abera Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Abera Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.7.5 Abera Recent Developments/Updates
  • 6.8 S K Chemicals
    • 6.8.1 S K Chemicals Corporation Information
    • 6.8.2 S K Chemicals Description and Business Overview
    • 6.8.3 S K Chemicals Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 S K Chemicals Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.8.5 S K Chemicals Recent Developments/Updates
  • 6.9 Beijing Minhai Biotechnology
    • 6.9.1 Beijing Minhai Biotechnology Corporation Information
    • 6.9.2 Beijing Minhai Biotechnology Description and Business Overview
    • 6.9.3 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.9.5 Beijing Minhai Biotechnology Recent Developments/Updates
  • 6.10 Baxter
    • 6.10.1 Baxter Corporation Information
    • 6.10.2 Baxter Description and Business Overview
    • 6.10.3 Baxter Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Baxter Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.10.5 Baxter Recent Developments/Updates
  • 6.11 Biken
    • 6.11.1 Biken Corporation Information
    • 6.11.2 Biken Streptococcus Pneumoniae Vaccine Description and Business Overview
    • 6.11.3 Biken Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Biken Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.11.5 Biken Recent Developments/Updates
  • 6.12 Celgene Corporation
    • 6.12.1 Celgene Corporation Corporation Information
    • 6.12.2 Celgene Corporation Streptococcus Pneumoniae Vaccine Description and Business Overview
    • 6.12.3 Celgene Corporation Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Celgene Corporation Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.12.5 Celgene Corporation Recent Developments/Updates
  • 6.13 Panacea Biotec
    • 6.13.1 Panacea Biotec Corporation Information
    • 6.13.2 Panacea Biotec Streptococcus Pneumoniae Vaccine Description and Business Overview
    • 6.13.3 Panacea Biotec Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Panacea Biotec Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.13.5 Panacea Biotec Recent Developments/Updates
  • 6.14 Serum Institute of India
    • 6.14.1 Serum Institute of India Corporation Information
    • 6.14.2 Serum Institute of India Streptococcus Pneumoniae Vaccine Description and Business Overview
    • 6.14.3 Serum Institute of India Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Serum Institute of India Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.14.5 Serum Institute of India Recent Developments/Updates
  • 6.15 Genentech
    • 6.15.1 Genentech Corporation Information
    • 6.15.2 Genentech Streptococcus Pneumoniae Vaccine Description and Business Overview
    • 6.15.3 Genentech Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 Genentech Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.15.5 Genentech Recent Developments/Updates
  • 6.16 Genocea Biosciences
    • 6.16.1 Genocea Biosciences Corporation Information
    • 6.16.2 Genocea Biosciences Streptococcus Pneumoniae Vaccine Description and Business Overview
    • 6.16.3 Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.16.5 Genocea Biosciences Recent Developments/Updates
  • 6.17 ImmunoBiology
    • 6.17.1 ImmunoBiology Corporation Information
    • 6.17.2 ImmunoBiology Streptococcus Pneumoniae Vaccine Description and Business Overview
    • 6.17.3 ImmunoBiology Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 ImmunoBiology Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.17.5 ImmunoBiology Recent Developments/Updates
  • 6.18 Lupin
    • 6.18.1 Lupin Corporation Information
    • 6.18.2 Lupin Streptococcus Pneumoniae Vaccine Description and Business Overview
    • 6.18.3 Lupin Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Lupin Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.18.5 Lupin Recent Developments/Updates
  • 6.19 Nuron Biotech
    • 6.19.1 Nuron Biotech Corporation Information
    • 6.19.2 Nuron Biotech Streptococcus Pneumoniae Vaccine Description and Business Overview
    • 6.19.3 Nuron Biotech Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Nuron Biotech Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.19.5 Nuron Biotech Recent Developments/Updates
  • 6.20 Biogen
    • 6.20.1 Biogen Corporation Information
    • 6.20.2 Biogen Streptococcus Pneumoniae Vaccine Description and Business Overview
    • 6.20.3 Biogen Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 Biogen Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.20.5 Biogen Recent Developments/Updates
  • 6.21 Valneva Austria
    • 6.21.1 Valneva Austria Corporation Information
    • 6.21.2 Valneva Austria Streptococcus Pneumoniae Vaccine Description and Business Overview
    • 6.21.3 Valneva Austria Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.21.4 Valneva Austria Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.21.5 Valneva Austria Recent Developments/Updates
  • 6.22 Sinovac
    • 6.22.1 Sinovac Corporation Information
    • 6.22.2 Sinovac Streptococcus Pneumoniae Vaccine Description and Business Overview
    • 6.22.3 Sinovac Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
    • 6.22.4 Sinovac Streptococcus Pneumoniae Vaccine Product Portfolio
    • 6.22.5 Sinovac Recent Developments/Updates

7 Streptococcus Pneumoniae Vaccine Manufacturing Cost Analysis

  • 7.1 Streptococcus Pneumoniae Vaccine Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Streptococcus Pneumoniae Vaccine
  • 7.4 Streptococcus Pneumoniae Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Streptococcus Pneumoniae Vaccine Distributors List
  • 8.3 Streptococcus Pneumoniae Vaccine Customers

9 Streptococcus Pneumoniae Vaccine Market Dynamics

  • 9.1 Streptococcus Pneumoniae Vaccine Industry Trends
  • 9.2 Streptococcus Pneumoniae Vaccine Growth Drivers
  • 9.3 Streptococcus Pneumoniae Vaccine Market Challenges
  • 9.4 Streptococcus Pneumoniae Vaccine Market Restraints

10 Global Market Forecast

  • 10.1 Streptococcus Pneumoniae Vaccine Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Streptococcus Pneumoniae Vaccine by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Streptococcus Pneumoniae Vaccine by Type (2022-2027)
  • 10.2 Streptococcus Pneumoniae Vaccine Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Streptococcus Pneumoniae Vaccine by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Streptococcus Pneumoniae Vaccine by Application (2022-2027)
  • 10.3 Streptococcus Pneumoniae Vaccine Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Streptococcus Pneumoniae Vaccine by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Streptococcus Pneumoniae Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    7 -Valent
    10 -Valent
    13 -Valent
    15 -Valent
    23 -Valent
    Other

    Segment by Application
    Children under 2 Years of Age
    Adults over 65 Years of Age
    Addicted Smokers Between the Ages of 19 and 64
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Pfizer
    Sanofi
    GSK
    Merck
    Eli Lilly
    AstraZeneca
    Abera
    S K Chemicals
    Beijing Minhai Biotechnology
    Baxter
    Biken
    Celgene Corporation
    Panacea Biotec
    Serum Institute of India
    Genentech
    Genocea Biosciences
    ImmunoBiology
    Lupin
    Nuron Biotech
    Biogen
    Valneva Austria
    Sinovac
    Buy now